Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, 730000, China
NCT Number: NCT06697405
This retrospective study investigates the relationship between cardiopulmonary bypass (CPB) duration and the incidence of gastrointestinal complications (GICs) in patients undergoing heart valve replacement. Patients will be grouped into a normal CPB group (CPB <120 minutes) and a prolonged CPB group (CPB ≥120 minutes). The study aims to determine whether prolonged CPB time is associated with a higher risk of GICs and to evaluate the outcomes and recovery process for patients who develop GICs postoperatively.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Lanzhou, Gansu, 730000, China
Heart valve replacement with CPB carries a risk of GICs due to potential ischemia-reperfusion injury to the gastrointestinal tract. GICs in the postoperative period can lead to increased morbidity and prolong recovery. Prolonged CPB time may serve as a predictive factor for the development of GICs following heart valve replacement. This study will utilize established diagnostic criteria to define GICs, which include clinical symptoms, laboratory tests, and imaging as necessary, based on standards from critical care and gastrointestinal surgery guidelines. By understanding this correlation, the study aims to reduce the incidence and severity of postoperative GICs and improve surgical outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention, regular therapy
Time frame: 1 month
The AGI score of the patient within the seventh postoperative day was performed daily according to the European Society of critical care (2012) guidelines for AGI. Determined the severity with grade 1-4,The higher the score, the more serious it is.
Time frame: 1 month
The time to first detection of bowel sounds after surgery, monitored daily in the morning and evening by auscultation.
Time frame: 1 month
The number of bowel sounds counted at 12-hour intervals, recorded twice daily to assess gastrointestinal motility.
Time frame: 1 month
The time to the first defecation was asked morning and evening after surgery.
Time frame: 1 month
Analysis of bacterial composition in the first stool sample post-surgery, focusing on the ratio of cocci to bacilli.
Time frame: 1 month
Maximum CRP level recorded within the first week after surgery.
Time frame: 1 month
Maximum PCT level recorded within the first week after surgery.
Time frame: 1 month
The investigators defined it as the maximum value of ALT within 7 days after surgery.
Time frame: 1 month
The investigators defined it as the maximum value of ALT within 7 days after surgery.
Time frame: 1 month
The investigators defined it as the maximum value of Creatinine within 7 days after surgery.
Time frame: 1 month
LVEF assessed through echocardiography on days 1 and 3 post-surgery to monitor cardiac function.
Time frame: 1 month
VAT was defined as the sum time of ventilator assisted post-surgery.
Time frame: 3 months
Total number of days during ICU, reflecting overall recovery and the impact of any gastrointestinal or systemic complications.
Hepatopancreatobiliary Surgery Institute of Gansu Province
Other
Incidence, Risk Factors, and Outcomes of Gastrointestinal Complications in Patients Undergoing Heart Valve Replacement With Cardiopulmonary Bypass
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03834155
Acute Myocardial Infarction, Angina Pectoris
Denver, Colorado, United States
View Trial DetailsNCT04527367
Aortic Valve Disease, Aortic Valve Stenosis
Bialystok, Poland
View Trial DetailsNCT03887286
Cardiovascular Abnormalities, Cardiovascular Diseases
Miami, Florida, United States
View Trial DetailsNCT01727310
Valvular Disease
Limoges, France
View Trial Details